Bristol-Myers Squibb (NYSE:BMY) is a top beaten-down dividend stock. Despite challenges, dividend stocks remain strong, attracting investors with stable business models and cash flows. BMY offers solid growth potential with a 4.80% dividend yield and strong financials.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing